Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

Abstract In six patients with chronic constipation, chronic active liver disease developed after one to two years of daily ingestion of laxative preparations containing oxyphenisatin; in a seventh liver disease occurred after ingestion of laxatives of unknown composition. Clinical features were jaundice, fatigue, firm hepatomegaly and, occasionally, spider angiomas and splenomegaly. Laboratory abnormalities included an increase in transaminase activity of 10 to 40 times, decreased prothrombin, depressed serum albumin and raised globulin. Two patients had positive LE-cell tests, two others had antinuclear antibody and three had smooth-muscle antibody; none had hepatitis-associated antigen. Liver biopsies showed areas of collapse and fibrosis, with stromal lymphocytic infiltrate and focal areas of hepatocytolysis. All patients improved after changing laxatives. Challenge with oxyphenisatin in three patients caused abrupt rises in transaminase activity. A toxic etiology should be considered, therefore, in al...

[1]  N. Mcintyre,et al.  Jaundice due to oxyphenisatin. , 1971, The Lancet.

[2]  K. Isselbacher,et al.  Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. , 1970, Lancet.

[3]  I. Mackay,et al.  Australia Antigen in Chronic Hepatitis in Australia* , 1970, British medical journal.

[4]  D. Alarcón-Segovia,et al.  Drug-induced lupus syndromes , 1969, British medical journal.

[5]  M. Bilitch,et al.  Procainamide-induced serologic changes in asymptomatic patients. , 1969, Arthritis and rheumatism.

[6]  S. Sherlock,et al.  Hepatitis-associated antigen in chronic liver disease. , 1969, Lancet.

[7]  G. Gleich,et al.  Australia antigen in chronic active liver disease with cirrhosis. , 1969, Lancet.

[8]  R. Wright,et al.  Australia antigen in acute and chronic liver disease. , 1969, Lancet.

[9]  I. Mackay,et al.  Smooth muscle autoantibody in "autoimmune" hepatitis. , 1966, Gastroenterology.

[10]  A. T. Ladd Procainamide-induced lupus erythematosus. , 1962, The New England journal of medicine.

[11]  J. Bickers,et al.  Hypersensitivity Reaction to Antituberculosa Drugs with Hepatitis, Lupus Phenomenon and Myocardial Infarction , 1961 .

[12]  A. H. Baggenstoss,et al.  Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus. , 1958, The New England journal of medicine.

[13]  P. Miescher,et al.  [L.E. phenomenon in two cases of drug hypersensitivity]. , 1953, Schweizerische medizinische Wochenschrift.

[14]  M. Kaufman PANCYTOPENIA FOLLOWING USE OF HYDRALLAZINE (APRESOLINE): REPORT OF A CASE , 1953 .

[15]  G. A. Emerson The Laxative Principle in Prunes , 1933 .